The Office of Pharmacy Affairs (OPA) recently published an update regarding the 340B ceiling price website. The update announces that HRSA will publish additional pricing data elements in the OPAIS…
A report prepared for 340B Health and published by L&M Policy Research shows that 340B hospitals care for a greater proportion of the underserved and low-income patient population than non-340B…
Last week, the U.S. District Court for the Southern District of Florida held that Sentry Data Systems Inc. can proceed in an antitrust lawsuit against CVS Pharmacy, Inc., alleging that…
On April 1, 2019, HRSA launched its secure pricing component of the 340B OPAIS. This long overdue website allows safety-net providers access to a database of 340B ceiling prices. The…
On February 26, 2019, top executives from seven of the largest pharmaceutical companies testified before the Senate Finance Committee attempting to defend the industry’s business practices. The major focus of…
In a letter dated February 11, 2019, CVS Caremark announced that it will not implement its plan to reduce payment rates for pharmacies owned by 340B covered entities. These cuts…
Earlier this week, CVS Caremark issued letters to 340B covered entity owned pharmacies announcing that it has delayed the scheduled cuts in reimbursement rates until April 1, 2019. In November…
On December 20th, the national hospital groups that brought a lawsuit against HHS over the continued delay of the implementation date of the 340B Ceiling Price and Manufacturer Civil Monetary…
On December 27, 2018, the U.S. District Court for the District of Columbia struck down the portion of the 2018 OPPS rule that cut Medicare Part B drug reimbursement to…
Earlier today, HHS published a final rule to implement the 340B Ceiling Price and Manufacturer Civil Monetary Penalties Rule (CMP Rule) on January 1, 2019. The Affordable Care Act (ACA)…